This was the stock's third consecutive day of losses.

In a report released today, Brandon Couillard from Wells Fargo maintained a Buy rating on Thermo Fisher (TMO – Research Report), with a price ...

Job cuts in Cambridge and Plainville are the second workforce reduction planned for the facilities in the past three months.

Medpace demonstrates strong financial performance and growth in the CRO market, despite facing challenges in the short term. Read why MEDP stock is a Strong Buy.

Healthcare stocks have jumped, but the easy money has already been made. The ETF, home to health insurers, drugmakers, and ...

Despite recent evidence of its financial turnaround, Thermo Fisher’s layoff spree will continue into 2025. | Despite recent ...

This week, explore what lurks in asteroid dust, marvel at the world’s largest beaded burial, discover an elusive creature ...

Stifel Nicolaus analyst Daniel Arias maintained a Buy rating on Thermo Fisher (TMO – Research Report) today and set a price target of $665.00.

Contentious hearings to consider Robert F. Kennedy Jr. to lead the Department of Health and Human Services this week have shined a spotlight on some of Washington’s […] ...

Advanced Therapeutics Pharmaceutical Outsourcing IndustryFuture Market Insights (FMI), a leading provider of industry analysis and market research, has unveiled its latest report highlighting the ...

Global Healthcare CRO Market Growth is Driven by Rising Investments in R&D, Regulatory Complexity, and Adoption of Decentralized Clinical Trials.Pune, Jan. 30, 2025 (GLOBE NEWSWIRE) -- “According to ...

We recently published a list of the 12 Best Stocks to Buy in 2025 for Beginners. In this article, we are going to take a look ...